ClinicalTrials.Veeva

Menu

Erector Spinae Plane Block (ESPB): in Patients Undergoing Surgery Through a Flank or Anterior Subcostal Incision.

Penn State Health logo

Penn State Health

Status and phase

Terminated
Phase 4

Conditions

Partial Nephrectomy
Nephrectomy
Incision Site Discomfort

Treatments

Drug: Normal saline
Drug: Ropivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT03691935
STUDY00008663

Details and patient eligibility

About

Using a randomized double-blinded study design, the study goal is to evaluate the superiority of Erector Spinae Plane block (ESPB) in the peri-operative pain management of patients undergoing surgery through a flank or anterior subcostal incision as compared to the standard of care of using IV and oral opiates.

Full description

40 subjects will be randomized in to 2 groups, with 20 in each group.

  • Group 1. Erector spinae plane block (ESPB) (containing Ropivacaine)
  • Group 2. Sham Erector spinae plane block. (SESPB) (with normal saline)

Enrollment

20 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consenting adults age 18-85
  • American Society of Anesthesiologists (ASA) Physical Status classification I to III
  • Planned to be hospitalized for at least 24 hours post-op
  • Cognitive capacity to use the visual analogic scale (VAS) and complete the patient satisfaction survey

Exclusion criteria

  • Patient refusal
  • Patients with allergies to local anesthetics or opiates (hydromorphone or oxycodone)
  • Scoliosis
  • Patients with chronic pain syndromes or who are on chronic pain medications/other neurologic medication of more than 3 months or whom have neuromodulators/stimulators
  • Concurrent surgeries requiring additional incisions on the body

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

20 participants in 2 patient groups

Ropivicaine
Experimental group
Description:
Erector Spinae Block of 20ml 0.5% ropivicaine bolus, connected to a pump containing 0.2% ropivicaine receiving 15ml every 3 hrs.
Treatment:
Drug: Ropivacaine
Normal Saline
Sham Comparator group
Description:
Erector Spinae Block of 20ml normal saline placebo bolus, then connected to pump of normal saline receiving 15ml every 3 hrs.
Treatment:
Drug: Normal saline

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems